<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    8764622
   </pmid>
   <datecreated>
    <year>
     1996
    </year>
    <month>
     10
    </month>
    <day>
     11
    </day>
   </datecreated>
   <datecompleted>
    <year>
     1996
    </year>
    <month>
     10
    </month>
    <day>
     11
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2009
    </year>
    <month>
     11
    </month>
    <day>
     19
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0093-0415
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       164
      </volume>
      <issue>
       6
      </issue>
      <pubdate>
       <year>
        1996
       </year>
       <month>
        Jun
       </month>
      </pubdate>
     </journalissue>
     <title>
      The Western journal of medicine
     </title>
     <isoabbreviation>
      West. J. Med.
     </isoabbreviation>
    </journal>
    <articletitle>
     Isoniazid-related fatal hepatitis.
    </articletitle>
    <pagination>
     <medlinepgn>
      486-91
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext>
      To describe the clinical and demographic characteristics of fatal hepatitis due to single-drug isoniazid preventive therapy for tuberculosis, we did a survey of cases from state health departments, published case reports, and reports to the Centers for Disease Control and Prevention from 1970 to 1992. Of 108 reported cases, some clinical information was available for 76. A medical review panel judged 39 of these deaths as probably due to isoniazid hepatitis and 23 deaths as possibly due to isoniazid hepatitis. Of the 62 probable and possible cases combined, 50 (81%) were female, 49 (79%) were non-Hispanic black or Hispanic, and 19 (31%) were younger than 35 years. The median duration of isoniazid preventive therapy before symptom onset was 16 weeks. Of the 60 cases with symptom information, 54 (90%) presented with jaundice. Of the 62 cases, 26 (42%) were monitored monthly in accordance with current recommendations, and 6 of the patients were younger than 35 years. We estimate that the rate of fatal isoniazid hepatitis among patients in the public sector was no greater than 4.2 per 100,000 persons beginning therapy and no greater than 7 per 100,000 persons completing therapy. Adherence to isoniazid preventive therapy guidelines apparently reduces, but does not eliminate, the risk of fatal hepatitis. Careful patient selection, education, and monitoring are critical for minimizing that risk.
     </abstracttext>
    </abstract>
    <affiliation>
     Family Practice Residency Program, Eastern Maine Medical Center, Bangor, USA.
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Millard
      </lastname>
      <forename>
       P S
      </forename>
      <initials>
       PS
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Wilcosky
      </lastname>
      <forename>
       T C
      </forename>
      <initials>
       TC
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Reade-Christopher
      </lastname>
      <forename>
       S J
      </forename>
      <initials>
       SJ
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Weber
      </lastname>
      <forename>
       D J
      </forename>
      <initials>
       DJ
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Research Support, Non-U.S. Gov't
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     UNITED STATES
    </country>
    <medlineta>
     West J Med
    </medlineta>
    <nlmuniqueid>
     0410504
    </nlmuniqueid>
    <issnlinking>
     0093-0415
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Antitubercular Agents
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      54-85-3
     </registrynumber>
     <nameofsubstance>
      Isoniazid
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    AIM
   </citationsubset>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      Gastroenterology. 1975 Aug;69(2):289-302
     </refsource>
     <pmid version="1">
      1150039
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      West J Med. 1993 Nov;159(5):560-4
     </refsource>
     <pmid version="1">
      8279152
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Pediatr. 1976 May;88(5):867-8
     </refsource>
     <pmid version="1">
      1271153
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Intern Med. 1959 Mar;50(3):804-10
     </refsource>
     <pmid version="1">
      13627721
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am Rev Respir Dis. 1962 Apr;85:490-510
     </refsource>
     <pmid version="1">
      13892318
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am Rev Respir Dis. 1963 Aug;88:161-75
     </refsource>
     <pmid version="1">
      14045220
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Chest. 1992 May;101(5):1298-301
     </refsource>
     <pmid version="1">
      1582287
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 1992 Jul 22-29;268(4):504-9
     </refsource>
     <pmid version="1">
      1619742
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):494-7
     </refsource>
     <pmid version="1">
      1736764
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Intern Med. 1991 Mar 1;114(5):431
     </refsource>
     <pmid version="1">
      1992890
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Public Health Rep. 1989 Mar-Apr;104(2):151-5
     </refsource>
     <pmid version="1">
      2495549
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am Rev Respir Dis. 1989 Sep;140(3):575-6
     </refsource>
     <pmid version="1">
      2782732
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am Rev Respir Dis. 1989 Sep;140(3):700-5
     </refsource>
     <pmid version="1">
      2782741
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am Rev Respir Dis. 1988 Jan;137(1):215-20
     </refsource>
     <pmid version="1">
      3276255
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Pediatr Infect Dis. 1986 Jul-Aug;5(4):490-1
     </refsource>
     <pmid version="1">
      3725664
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 1986 Nov 21;256(19):2709-13
     </refsource>
     <pmid version="1">
      3773178
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 1986 Nov 21;256(19):2729-30
     </refsource>
     <pmid version="1">
      3773185
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Md State Med J. 1974 Nov;23(11):64-7
     </refsource>
     <pmid version="1">
      4420979
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Intern Med. 1973 Jul;79(1):1-12
     </refsource>
     <pmid version="1">
      4721174
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am Rev Respir Dis. 1972 Sep;106(3):357-65
     </refsource>
     <pmid version="1">
      5080707
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am Rev Respir Dis. 1967 Jun;95(6):935-43
     </refsource>
     <pmid version="1">
      6026165
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am Rev Respir Dis. 1978 Jun;117(6):991-1001
     </refsource>
     <pmid version="1">
      666111
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      West J Med. 1996 Nov;165(5):323
     </refsource>
     <pmid version="1">
      8993215
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adolescent
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Antitubercular Agents
     </descriptorname>
     <qualifiername majortopicyn="Y">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Child
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Child, Preschool
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="Y">
      Drug-Induced Liver Injury
     </descriptorname>
     <qualifiername majortopicyn="N">
      epidemiology
     </qualifiername>
     <qualifiername majortopicyn="N">
      etiology
     </qualifiername>
     <qualifiername majortopicyn="N">
      mortality
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Incidence
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Isoniazid
     </descriptorname>
     <qualifiername majortopicyn="Y">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Male
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Middle Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Risk
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Survival Rate
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Tuberculosis
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug therapy
     </qualifiername>
     <qualifiername majortopicyn="N">
      prevention &amp; control
     </qualifiername>
    </meshheading>
   </meshheadinglist>
   <otherid source="NLM">
    PMC1303623
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      1996
     </year>
     <month>
      6
     </month>
     <day>
      1
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      1996
     </year>
     <month>
      6
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      1
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      1996
     </year>
     <month>
      6
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     8764622
    </articleid>
    <articleid idtype="pmc">
     PMC1303623
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

